Company ProfilePremium

Axel Polymers Limited

Company Profile Analysis

Ticker: 513642.BO

ESOMAR 23 Corporate BadgeISO Certifications Badge
Axel Polymers Limited - Company showcase

Year Founded & Workforce

1992

Axel Polymers Limited logo

Axel Polymers Limited Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Axel Polymers Limited Overview

Axel Polymers is a micro-cap, single-plant polymer compounder based in Savli, Vadodara, in Gujarat's petrochemical belt. It converts base resins into compounds, blends and alloys of engineering, specialty and commodity polymers, and also trades polymer compounds. The company describes itself as "the largest manufacturer of Engineering Thermoplastic Compounds in India". That claim is not supported by its scale. FY2026 revenue was about ₹44 Cr, which is under 3% of the ₹1,996 Cr reported by listed peer Kingfa Science & Technology (India), and APPL Industries also markets itself as India's largest pure engineering-plastics compounder. The more accurate characterisation is a small, highly leveraged, promoter-controlled converter. It reached a reverse-merger-driven revenue peak of ₹128 Cr in FY2024, then saw revenue fall about 65% over two years. Today it operates under an auditor-flagged going-concern material uncertainty, a ₹31.57 Cr GST input-tax-credit show-cause notice, and parallel SEBI and Income-tax investigations. Equity value is currently driven mainly by the legal outcome of those proceedings rather than by industrial fundamentals.


Company's own description (FY2025 Board's Report, 33rd report). Axel says it was established in 1992 and is principally engaged in two activities: manufacturing compounds, blends and alloys of engineering and specialty polymers, and trading polymer compounds. It says it serves multinational and domestic corporates and draws on about three decades of experience in international and local polymer markets. Broker profiles (Kotak Neo, citing company material) list its end-industries as automotive, home appliances, electrical and electronics, construction, packaging and healthcare.

What the company actually does. Axel sits in the middle of the plastics value chain. Upstream are petrochemical producers making base resins such as polypropylene, polyamides, polycarbonate, ABS, PBT and POM. Axel buys these resins, mostly domestically and partly through imports, and melt-compounds them on extrusion lines. In compounding, the resin is mixed with reinforcements (glass fibre, mineral fillers), impact modifiers, flame retardants, stabilisers and colourants to produce application-specific pellets. Downstream customers are injection moulders and tier-1 or tier-2 component suppliers, who turn the pellets into automotive interior and under-hood parts, appliance housings, electrical fittings and similar items. The company's grade-level catalogue was not available in the sources reviewed.

Business and revenue model.

Independent characterisation. Commercially, Axel is a sub-scale commodity-to-engineering compounder with thin margins. Over FY2022–FY2025, operating profit (EBITDA basis) was ₹4–6 Cr on revenue of ₹73–128 Cr, and net margins never exceeded 1.5%. Net debt has been roughly six to ten times EBITDA. The swing in reported turnover is very large. Revenue rose from ₹22.9 Cr in FY2020 to ₹127.9 Cr in FY2024, then fell to ₹44.4 Cr in FY2026. This tracks two events: the September 2021 amalgamation of promoter entity Dhara Petrochemicals, and the July 2024 GST search. The GST authorities allege that input tax credit was availed without physical receipt of goods and passed on without actual supply. If upheld, that allegation would imply that part of the FY2022–FY2025 trading turnover was not genuine commercial supply. The company contests this. Investors should treat historical revenue peaks with caution until the proceedings are resolved.

Strategy

Stated strategy. Axel has not published an investor presentation, investor-day material or medium-term targets. The themes in its disclosures are:

Domain positioning: it presents itself as a leading Indian engineering-thermoplastics compounder with three decades of experience, serving MNC and domestic customers (FY25 Board's Report).

Operational response to the downturn (FY2026 annual report): improving operational efficiency, optimising manufacturing costs, strengthening procurement and maintaining financial discipline.

Balance-sheet repair: an equity raise to fund working capital and capex.

Initiatives in the last 24 months.

ESG commitments, transformation programmes with targets, new business launches and partnerships: none publicly disclosed. Guidance: none issued.

Sources: BSE Reg. 30 and Reg. 32 filings via FinancialFilings, Screener and Investywise; ScanX.

Products & Services

Disclosure limitation. The annual-report extracts and exchange filings reviewed do not publish a product catalogue, brand names, grade specifications, launch years or pricing. The portfolio below is therefore organised by the product families Axel discloses, with the typical characteristics of each family. Named grades and brands are marked "not publicly disclosed".

Sources: FY2025 Board's Report; Value Research/Simply Wall St profiles (engineering, specialty and commodity polymers); Kotak Neo profile (end-industries). The "typical capabilities" column reflects industry norms, not Axel-specific specifications.

Analyst note. FY2026 gross margin, as transcribed by StockAnalysis, rose to about 23% from 10–15% in prior years while revenue halved. A plausible reading is that low-margin trading volume shrank sharply after July 2024, leaving a higher-margin manufactured core of roughly ₹40–45 Cr. This is an inference; the company has not disclosed a manufactured-versus-traded split.

Product Portfolio

Product family (as disclosed)DescriptionTypical capabilitiesTarget customers / end-marketsNamed flagship / brandLaunch / pricing

Engineering thermoplastic (ETP) compounds

Reinforced or modified engineering resins compounded to customer specifications

Higher heat resistance, stiffness, dimensional stability and impact strength than commodity resins

Automotive components, electrical & electronics, appliances

—

Not publicly disclosed; resin-indexed pricing typical

Specialty polymer compounds

Compounds with functional additives, such as flame-retardant, UV-stabilised or colour-matched grades

Application-specific performance (FR ratings, weathering, aesthetics)

E&E, construction, healthcare

——

Polymer blends & alloys

Two or more polymers combined to balance properties

Balanced toughness, processability and heat resistance

Automotive interiors, appliance housings

——

Commodity polymer compounds

Filled or modified commodity resins

Cost-optimised stiffness and processing

Packaging, consumer goods, appliances

——

Traded polymer compounds

Third-party compounds or resins resold

No conversion; low margin

Same customer base

Not applicable

—

“—” = not publicly disclosed.

Financial Narrative

Income statement

Sources: StockAnalysis (₹ million, converted) for revenue, gross profit, EBIT, interest, PBT and tax; Screener for EBITDA FY22–FY25; FY26 EBITDA derived as EBIT ₹1.82 Cr plus depreciation ₹0.73 Cr (Fyers). FY2025 Board's Report: revenue ₹7,808.52 lakh, PBT ₹31.14 lakh, PAT ₹17.35 lakh; FY2024 revenue ₹12,791.61 lakh, PBT ₹228.62 lakh, PAT ₹155.59 lakh. FY2026: PBT −₹125.49 lakh; PAT −₹112.63 lakh, also reported as −₹112.64 lakh. EPS FY22–FY24 derived on 85.17 lakh shares; FY25–FY26 as reported (₹0.20; −₹1.02). Trendlyne: no dividends since at least 2000.

Margins and growth

Derived from 6.1. Revenue CAGR FY2022→FY2026 is −11.6% (derived). FY2021→FY2024 CAGR is +38.0% (derived, from ₹48.32 Cr). Screener's 5-year sales CAGR is 14% and 3-year is −19% (Fyers).

Commentary. The income statement has three phases. In FY2021–FY2024, revenue expanded rapidly but profit barely moved. Revenue grew 2.6× from FY2021 to FY2024, yet EBITDA rose only from ₹3.9 Cr to ₹5.8 Cr. Gross margin compressed from 14.9% to 10.0%, which suggests the incremental turnover was low-value-add, probably trading. In FY2025, revenue fell 39% after the July 2024 GST search and the loss of the ₹42 Cr-per-quarter run-rate seen in Q1 FY25. Profit was rescued only by an unusual ₹2.23 Cr Q4 profit; Q4 FY25 operating margin was 23.03% per MarketsMojo. In FY2026, revenue fell a further 43% to ₹44.4 Cr. Gross margin rose to 23%, but fixed costs and finance costs of ₹3.08 Cr, the highest in five years, pushed the company to a pre-tax loss. Management attributed the decline to lower operating revenue, weak demand in certain customer segments, competitive pricing pressure and raw-material volatility (FY2026 annual report via Investywise). In every year, interest absorbed 50–120% of EBIT. This is the central structural weakness.

Balance sheet

Sources: VogueStock/BFSL (annual-report balance sheets FY21–FY25); StockAnalysis (cash, receivables, net debt FY22–FY26); MarketsMojo (FY25 borrowings ₹34.08 Cr, +32.8% YoY). FY26 total debt derived as net debt plus cash. FY26 share capital derived (110.0 lakh shares × ₹10). FY26 equity is an analyst estimate: FY25 equity + ₹11.18 Cr issue proceeds − ₹1.13 Cr loss. It is consistent with a P/B of ~1.9–2.1 at a market cap of ₹49–54 Cr. Eulerpool reports long-term debt/equity of 0.43 in 2026 against 0.47 previously.

Commentary. The ₹3.8 Cr of intangible assets appeared in FY2022 alongside the DPPL amalgamation and has not been amortised or impaired. Its nature (goodwill versus other intangibles) is not detailed in the sources reviewed and deserves scrutiny given the going-concern note. Short-term borrowings jumped ₹9 Cr in FY2025 even as revenue fell 39%, which indicates the working-capital cycle was lengthening. The December 2025 equity raise appears to have reduced gross debt by about ₹4 Cr in FY2026. ₹6.71 Cr of proceeds went to working capital (Reg. 32 statement), which probably substituted for bank lines.

Cash flow

Sources: Bajaj Broking (net change in cash). Preferential-issue Reg. 32 statement: ₹2.24 Cr of issue proceeds allocated to and fully used for capex by 31 Mar 2026. Total FY26 capex may differ. MarketsMojo's commentary refers to "negative cash flow dynamics" in FY2026. StockAnalysis cash growth for FY23 (+14.5%) is inconsistent with Bajaj Broking's net change, probably because of differing treatment of bank balances.

Key ratios

Derived from 6.1 and 6.3 using average equity and assets, except: FY24 ROE (10.9%) and current ratio (1.23) from Finology; FY25 ROE (1.15%) and ROCE (7.19%) from mStock; Screener reports debtor days rising from 38.9 to 51.6 (FY24→FY25). FY26 debt/equity uses estimated equity. The inventory and payables components of the cash conversion cycle are not publicly disclosed; Equitymaster reports net working capital at 8.9–10.8% of sales in FY21–FY23.

Ratio commentary. Returns on equity of about 9–13% in FY2022–FY2024 were produced by leverage (debt/equity of about 2×) on a thin equity base, not by operating returns. ROA never exceeded 2.6%. Interest coverage below 1.0× in FY2026 means the company is not earning its interest bill. The equity raise mechanically improves gearing but does not fix earnings power. Receivable days doubled between FY2024 and FY2026, which points to weaker collections or a smaller, slower-paying customer mix.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Revenue by Segment and Segment Margins & Growth (%)

MetricFY2022FY2023FY2024FY2025FY2026

Polymer compounds segment revenue (INR Cr)

72.9282.65127.9278.0944.40

Segment YoY growth (%)

50.913.454.8-39.0-43.2

Contribution to total revenue (%)

100100100100100

Segment pre-tax income (INR Cr)

1.341.702.290.31-1.25

Segment pre-tax margin (%)

1.82.11.80.4-2.8

Revenue by Segment

MetricQ1FY25Q2FY25Q3FY25Q4FY25Q1FY26Q2FY26Q3FY26Q4FY26Q1FY27

Revenue (INR Cr)

42.2413.8711.1114.3311.7010.748.8613.1216.2

Net profit (INR Cr)

-0.53-0.81-0.762.230.040.01-0.62-0.82—

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Income Statement and Margin Analysis (%)

MetricFY2022FY2023FY2024FY2025FY2026

Revenue from operations (INR Cr)

72.9282.65127.9278.0944.40

Revenue growth (%)

50.913.454.8-39.0-43.2

Gross profit (INR Cr)

10.8811.5112.7411.1410.21

Operating income / EBIT (INR Cr)

4.014.755.113.411.82

EBITDA (INR Cr)

4.115.125.793.962.55

Finance costs (INR Cr)

2.682.822.412.723.08

Pre-tax income (INR Cr)

1.341.702.290.31-1.25

Income tax (INR Cr)

0.430.520.730.14-0.13

Net income (INR Cr)

0.921.181.560.17-1.13

EPS basic (INR)

1.081.391.830.20-1.02

EPS diluted (INR)

1.081.391.830.20-1.02

Dividend per share (INR)

00000

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Margin Analysis (%)

MetricFY2022FY2023FY2024FY2025FY2026

Gross margin (%)

14.913.910.014.323.0

Operating (EBIT) margin (%)

5.55.74.04.44.1

EBITDA margin (%)

5.66.24.55.15.7

Net margin (%)

1.261.431.220.22-2.54

Balance Sheet

MetricFY2021FY2022FY2023FY2024FY2025FY2026

Total assets (INR Cr)

22.1055.3655.6264.4867.42—

Cash & equivalents (INR Cr)

—0.941.081.032.183.31

Long-term borrowings (INR Cr)

1.424.946.477.096.46—

Short-term borrowings (INR Cr)

7.3520.9918.7218.5827.62—

Total debt (INR Cr)

8.7725.9325.1925.6734.0829.84

Net debt (INR Cr)

—25.0024.1224.6431.9026.53

Share capital (INR Cr)

4.308.528.528.528.5211.00

Reserves & surplus (INR Cr)

-2.103.815.016.476.62—

Total equity (INR Cr)

2.2012.3213.5314.9915.1425.2

Intangible assets incl. goodwill (INR Cr)

03.793.803.793.78—

Net tangible fixed assets (INR Cr)

3.363.925.045.986.40—

Trade receivables (INR Cr)

—12.307.8410.7211.159.50

Trade payables (INR Cr)

7.1016.1715.6022.5116.74—

Total current liabilities (INR Cr)

14.7037.8235.3442.0745.52—

Cash Flow

MetricFY2022FY2023FY2024FY2025FY2026

Capital expenditure (INR Cr)

————2.24

Net change in cash (INR Cr)

0.200.83-0.041.151.12

Equity issued (INR Cr)

000011.18

Dividends paid (INR Cr)

00000

Buybacks (INR Cr)

00000

Returns & Leverage Ratios (%) and Financial Ratios (x)

MetricFY2022FY2023FY2024FY2025FY2026

ROE (%)

12.79.110.91.15-5.6

ROA (%)

2.42.12.60.3—

ROCE (%)

———7.2—

Current ratio (x)

——1.23——

Debt / equity (x)

2.101.861.712.251.18

Net debt / EBITDA (x)

6.14.74.38.110.4

Interest coverage, EBIT / interest (x)

1.501.682.121.250.59

Asset turnover (x)

1.881.492.131.18—

Receivable days

6235315278

Results by Region

MetricFY2019FY2020FY2021FY2022FY2023

Net foreign exchange, earnings minus outgo (INR Mn)

0-2-2-8-18

Valuation Snapshot

MetricValueAs ofSource

Latest verified price (INR)

49.01

26 Aug 2026

Value Research

52-week high / low (INR)

60.00 / 27.72 to 34.51 (window-dependent)

Mid-2026

Simply Wall St; Torus; Business Today

1-year return (%)

-12.8

~Jul 2026

Simply Wall St

3-year return (%)

-9.6

~Jul 2026

Simply Wall St (Value Research: −0.63% to May 2026)

5-year return (%)

+294

~Jul 2026

Simply Wall St (IIFL 5-yr CAGR: 26.4% as of Feb 2026)

Beta

-0.17—

Simply Wall St

Liquidity

Very thin; daily volumes often in the tens to hundreds of shares

2,026

Emkay; MarketsMojo; Trendlyne

Metric

FY2022

FY2023

FY2024

EPS (INR)

1.081.391.83

Book value per share (INR)

14.515.917.6

Capital Markets

MetricAxel PolymersPlastiblends India

Market cap (INR Cr)

54437

P/E (x)

Negative (TTM loss)

13.1

P/B (x)

2.1—

EV/Sales (x)

1.8—

EV/EBITDA (x)

31.6—

Capital Markets — Dividend history

ItemDetail

Dividend history

None since at least 2000 (Trendlyne)

Dividend policy

None formally disclosed

Bonus / split

None since 2000

Credit ratings (Moody's / S&P / Fitch)

Not rated. No domestic agency (CRISIL, ICRA, CARE, India Ratings) rating found in reviewed sources.

Debt maturity profile

FY25: ₹27.62 Cr short-term (working-capital lines, due within 12 months) and ₹6.46 Cr long-term (term loans). Detailed maturity ladder not publicly disclosed.

Analyst consensus

No sell-side coverage (Simply Wall St: 0 analysts). MarketsMojo algorithmic rating: "Strong Sell" (score 17).

Analyst Conclusions

Management guidance. None issued. The FY2026 commentary is qualitative: continued focus on operational efficiency, manufacturing cost optimisation, procurement and financial discipline. Consensus. No sell-side coverage exists.

Bull case

  1. Volume recovery is under way. Q1 FY27 revenue of about ₹16 Cr is up about 38% YoY and is the best quarter since Q2 FY25. With gross margin near 23% and a fixed-cost base already absorbed, returning to ₹60–70 Cr annual revenue could restore EBITDA to the ₹4–5 Cr range seen in FY22–FY24 (scenario).

  2. Balance sheet repaired at the margin. The ₹11.18 Cr raise cut net debt by about ₹5.4 Cr and halved debt/equity to about 1.2×. Interest costs should fall from FY26's ₹3.08 Cr peak as working-capital funding shifts from bank lines to equity.

  3. The GST demand may not survive. The company contests the SCN on the basis of CBIC Circular 171/03/2022. A favourable order would remove the specific trigger for the auditor's going-concern note and could re-rate the stock in a structurally growing ETP market (7.4% CAGR per IMARC).

Bear case

  1. Equity-threatening contingent liability. A ₹31.57 Cr GST demand, plus interest and penalty, against about ₹25 Cr of estimated net worth means an adverse order alone could render the company balance-sheet insolvent. Separately, ₹18 Cr of cheque litigation is outstanding.

  2. Historical revenue may be partly non-commercial. Revenue tripled between FY2021 and FY2024 while gross margin compressed, then collapsed immediately after the July 2024 GST search. That pattern is consistent with the authorities' allegation of ITC passed on without actual supply. If substantiated, the "true" business is about ₹40–50 Cr of revenue with marginal profitability, and prior valuations rested on inflated turnover.

  3. Regulatory escalation to directors. SEBI's September 2026 adjudication names the company and its non-independent directors. Combined with a combined CMD role, a delayed FY26 filing and promoter-group selling just before the December 2025 allotment, governance risk is high and could restrict access to bank credit and MNC customer approvals.

Catalysts and monitorables (next 12 months)

CatalystExpected timingWhy it matters
GST adjudication order / personal hearingIndeterminateSingle largest value driver
SEBI adjudication outcome (reply, hearing, order)3–12 monthsPenalties; possible restrictions on directors
Q2 FY27 results (Sep 2026 quarter)By mid-Nov 2026Confirms or refutes the Q1 FY27 recovery; resolves the Q1 PAT discrepancy
Income-tax investigation updatesIndeterminateUnquantified exposure
Section 138 cheque case developmentsIndeterminate₹18 Cr exposure
Bank facility renewals / any credit ratingOngoingLiquidity under going-concern note
Further equity raises or promoter infusionPossibleDilution versus solvency support
FY27 audit opinion (May 2027)Q1 FY28Whether the going-concern note is lifted, repeated or modified

Analyst verdict

Axel Polymers is not, on the evidence, what its self-description suggests. The claim to be India's largest engineering-thermoplastics compounder does not survive contact with the numbers. FY2026 revenue of ₹44.4 Cr is roughly one-forty-fifth of Kingfa India's, and at least one unlisted rival makes the same claim. The listed entity is a single-plant Gujarat compounder with a promoter-related reverse-merger history and five years of sub-1.5% net margins earned only through leverage of about 2×. Its turnover peak of ₹128 Cr in FY2024 now looks inseparable from the trading activity under GST scrutiny.

The investment case has narrowed to a binary legal question. If the ₹31.57 Cr ITC demand is substantially upheld, with interest and penalty added, the equity is likely impaired beyond recovery. The auditor has already linked its going-concern material uncertainty to exactly this notice. If the demand is quashed or materially reduced, what remains is a modest but real manufacturing business. It has improved gross margins (~23%), a lighter balance sheet after the ₹11.2 Cr equity raise, and a tentative volume recovery in Q1 FY27 against a structurally growing domestic ETP market.

Even the favourable scenario does not obviously justify the current valuation of about 2× book and about 30× trailing EV/EBITDA for a business that has not covered its interest bill in the latest year. SEBI's September 2026 adjudication against the company and its non-independent directors adds a governance dimension. Thin liquidity, a combined CMD role, a delayed annual filing and pre-allotment promoter selling all argue for a substantial discount rather than a premium.

On balance, risk-reward is unfavourable. The stock is appropriate only for special-situation capital able to underwrite Indian tax-litigation outcomes. Everyone else should wait for the GST adjudication order and the FY2027 audit opinion before taking a position.


SOURCES CONSULTED

  • BSE Ltd corporate filings (scrip 513642): results letters 13 Aug 2019, 11 Nov 2020, 9 Feb 2021, 29 Aug 2022, 29 May 2025, 24 Jul 2025, 2 Jun 2026; Reg. 30 and Reg. 32 disclosures (via bseindia.com, FinancialFilings, Business Standard media)

  • FY2025 Board's Report (33rd), reproduced by IIFL/IndiaInfoline

  • FY2026 audited results and auditor's report, via FinancialFilings, Investywise, ScanX

  • StockAnalysis.com — income statement and balance sheet (BOM:513642)

  • Screener.in; Fyers; MarketsMojo/Motilal Oswal; VogueStock (BFSL); Equitymaster; Value Research; Simply Wall St; Trendlyne; Tickertape (Capital Market); IndMoney; Bajaj Broking; Bajaj Finserv Markets; Emkay Global; Nirmal Bang; Kotak Securities / Kotak Neo; ICICIdirect; Torus Digital; Business Today; mStock; Eulerpool; Multibagg; Finology Ticker

  • Peers: Quartr and Business Standard/Capital Market (Kingfa India); Business Standard, Simply Wall St, Torus (Plastiblends); Plastemart (APPL Industries)

  • Market data: IMARC Group (India engineering plastics); MarketsandMarkets (India engineering plastics, plastic compounds, high-performance compounds); Ken Research (India automotive plastics)

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Board of Directors

NameRoleCategoryTenure / appointmentNotes

Gaurav Surendra Thanky

Chairman & Managing Director

Executive, promoter

Appointment date not disclosed in reviewed sources; signs all recent filings

Largest shareholder (32.9% post-issue; 42.39% pre-issue). Mumbai-based per digital-signature metadata. Education, age and prior roles not publicly disclosed.

Dhara Gaurav Thanky

Director

Non-executive, woman director, promoter group

—

Holds 2.02%. Name matches the amalgamated Dhara Petrochemicals Pvt. Ltd.

Aarasp B. Bodhanwala

Director

Promoter group

—

Holds 8.41% after selling 60,986 shares on 3 Dec 2025

Chirag Shah

Director

Non-executive independent (additional director per Emkay)

——

Ashokkumar Natwarlal Shah

Director

Non-executive independent

18 Aug 2025, five-year term

Appointed alongside committee reshuffle

Yogesh Keshariya

Director

Additional non-executive independent

12 Jun 2026

DIN 07063024; regularisation expected at the 34th AGM

Ashish Chaudhary

Listed in management

——

Named by Nirmal Bang

Company Secretary & Compliance Officer

—

KMP

——

“—” = not publicly disclosed.

Governance Overview

AttributeStatusAssessment

Chair/CEO separation

Combined (CMD)

Weak: concentrates control in the promoter

Board size

~6 directors

Small

Independence

3 independents (two added in the last 14 months)

Minimum compliance; recent arrivals may reflect board refresh under regulatory scrutiny

Family representation

CMD, spouse and a promoter-group director

High promoter influence

Committees

Audit, Nomination & Remuneration, Stakeholders' Relationship (reconstituted Aug 2025)

Present, but LODR Regulations 17–27 were historically inapplicable because of size (2020 filing). Applicability after the capital raise is unclear.

Compliance events

Delayed filing of FY26 results (Jun 2026 disclosures); CS resignation (Dec 2024); SEBI adjudication SCN (Sep 2026) naming non-independent directors

Elevated governance risk

Major Shareholders

HolderSharesStake (%)ChangeSource

Gaurav Thanky (promoter)

3,626,28832.9

0% (stake diluted by issue)

Simply Wall St

Aarasp Bodhanwala (promoter group)

926,0348.41-6.18%

Simply Wall St

Dhara Thanky (promoter group)

222,5712.020%

Simply Wall St

Tejal Dattani

126,6101.15+18.3%

Simply Wall St

Chirag Mehta

107,0000.970%

Simply Wall St

Devendra Patel

103,7000.940%

Simply Wall St

Vaibhav Equisec Pvt. Ltd.

100,0000.910%

Simply Wall St

Minnie Bodhanwala

96,9850.88-13.8%

Simply Wall St

Harsha Venkatesh

91,7500.83+0.82%

Simply Wall St

Mahendra Patel

47,8000.430%

Simply Wall St

Category

Stake (%)

———

Individual insiders / promoters

49.6———

General public

49.5———

Institutions

0.9———

Competitive Landscape

Key Competitors

#CompetitorTypeOverlap with AxelLatest revenueRelative positioning
1

Kingfa Science & Technology (India) Ltd

Listed (BSE 524019 / NSE KINGFA); Chinese-parent subsidiary

Reinforced PP, ETP compounds, TPE for auto and appliances

₹1,995.6 Cr (FY26); PAT ₹185.3 Cr

Scale leader in listed compounding, about 45× Axel's revenue

2

Plastiblends India Ltd

Listed (NSE PLASTIBLEN)

Masterbatches and specialty compounds

₹780.5 Cr (FY25); PAT ₹33.4 Cr

Larger, profitable, dividend-paying

3

APPL Industries Ltd

Unlisted

Pure ETP compounding (PP, PA blends, reinforced grades)

—

Claims to be India's largest pure engineering-plastics compounder, which contests Axel's own claim

4

SABIC (India operations)

Global major

ETP resins and compounds (PC, PBT, PP compounds)

—

Technology and brand leader

5

Polyplastics / Asahi Kasei-type Japanese ETP majors

Global majors with Indian sales

POM, PBT, PA, mPPE compounds

—

Premium OEM-approved grades

6

BASF India (performance materials)

Listed parent subsidiary

PA and PBT compounds

—

Premium auto and E&E grades

7

Envalior / Celanese / DuPont-legacy ETP businesses

Global

PA, POM, high-temperature polymers

—

Specification-driven

8

Domestic regional compounders (Gujarat/Maharashtra)

Unlisted SMEs

Commodity and filled compounds

—

Price competitors

9

Pearl Polymers, Narmada Macplast, Technopack Polymers, Aik Pipes & Polymers

Listed micro-caps (Business Standard peer set)

Broad plastics; limited direct compound overlap

—

Peer group for valuation only

“—” = not publicly disclosed.

Peer Comparison FY2025

MetricAxel PolymersKingfa IndiaPlastiblends India

Revenue, latest FY (INR Cr)

44.40 (FY26)

1995.55 (FY26)

780.45 (FY25)

Revenue growth, latest FY (%)

-43.214.4-2.7

Net profit, latest FY (INR Cr)

-1.13185.2633.44

Net margin (%)

-2.59.34.3

Operating margin, OPM (%)

5.7 (EBITDA)

12.9 (FY25)

6.7 (FY25)

Recent Developments

Layoffs or hiring: not publicly disclosed.*

Company Snapshot

$5.1M

Revenue

1992

Founded

Mumbai, India

Headquarters

SWOT Analysis

Strengths

  • Long operating history. Incorporated 21 May 1992; the company cites three decades in engineering polymer compounding (FY25 Board's Report).
  • Strategic plant location. Its Savli, Vadodara plant sits in Gujarat's petrochemical hub, near resin feedstock and western-India OEM clusters, which Ken Research identifies as the dominant automotive-plastics region.
  • Recent equity infusion. ₹11.18 Cr raised in December 2025 cut net debt from ₹31.9 Cr to ₹26.5 Cr (FY25→FY26) and lifted cash to ₹3.31 Cr, a five-year high (StockAnalysis).
  • Clean use of proceeds. Reg. 32 statements for Q4 FY26 and Q1 FY27 report no deviation, and the monitoring statement was signed off by the statutory auditor.
  • Improving gross margin. Gross margin was about 23% in FY26 versus 10% in FY24 (derived from StockAnalysis), suggesting a richer manufactured mix.
  • Signs of volume recovery. Q1 FY27 revenue of about ₹16 Cr is the highest since Q2 FY25 and up about 38% YoY from ₹11.70 Cr.

Weaknesses

  • Sub-scale. FY26 revenue of ₹44.4 Cr is about 2.2% of Kingfa India's ₹1,995.6 Cr.
  • Chronically thin profitability. Net margin has not exceeded 1.43% in five years; FY26 was −2.54%.
  • Interest burden. EBIT/interest was 0.59× in FY26; finance cost of ₹3.08 Cr exceeded EBIT of ₹1.82 Cr.
  • Leverage. Net debt/EBITDA rose to 10.4× in FY26 (derived) and short-term borrowings jumped 49% in FY25 to ₹27.6 Cr (BFSL).
  • Collections. Receivable days lengthened to about 78 in FY26 from about 31 in FY24 (derived).
  • No dividend history and no disclosed R&D. No dividends since at least 2000 (Trendlyne) and no R&D or patent disclosure.

Opportunities

  • Market growth. India ETP market forecast to grow 7.43% a year to USD 16.67 bn by 2034 (IMARC).
  • EV localisation. EV and auto-component localisation is identified as a key opportunity in IMARC's outlook, with automotive plastics growing at 8.2% CAGR (Ken Research).
  • Favourable outcome on GST. The company contests the SCN by citing CBIC Circular 171/03/2022-GST. A favourable adjudication would remove the going-concern trigger, since the auditor ties the uncertainty specifically to the SCN.
  • Operating leverage. With fixed costs and SG&A of ₹3.9 Cr already absorbed, a return to the FY23 revenue level (₹83 Cr) at FY26 gross margins could restore meaningful profit (scenario, not guidance).
  • Board refresh. Two new independent directors (Aug 2025, Jun 2026) could improve governance credibility with customers and lenders.
  • Further equity raises. Approval was for ₹12.73 Cr but only ₹11.18 Cr was raised, suggesting investor appetite exists at about ₹45/share.

Threats

  • GST demand. ₹31.57 Cr plus interest and penalty, about 1.25× estimated FY26 net worth of ~₹25 Cr (derived). An adverse order could wipe out equity.
  • SEBI adjudication. The 11 Sep 2026 SCN targets the company and its non-independent directors, with possible penalties or market restrictions.
  • Income-tax investigation. Initiated after the GST proceedings; contingent liability not quantifiable (FY26 annual report).
  • Cheque litigation. A Section 138 Negotiable Instruments Act proceeding with a vendor involves nine post-dated cheques totalling ₹18 Cr, about 40% of FY26 revenue.
  • Going concern. The material uncertainty in the FY26 audit report may tighten bank lines and supplier credit.
  • Competitive pricing. Management itself cited competitive pricing pressure in FY26, and larger rivals continue to grow (Kingfa FY26 +14.4%).

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
29 May 2025FY2025 audited results: revenue ₹78.1 Cr (−39%), PAT ₹0.17 Cr (−89%). Q4 FY25 PAT ₹2.23 Cr.Confirms post-GST-search reset
10 Jun 2025Share price ~₹34.87; market cap ~₹29.7 Cr; P/E ~174× (IIFL)Valuation near cycle low
26 Jun 2025Trading window closure ahead of Q1Routine
20–24 Jul 2025Board meeting intimation, then approval of Q1 FY26 results and the preferential issueCapital raise launched
24 Jul 2025Q1 FY26: revenue ₹11.70 Cr (−72.3% YoY); PAT ₹0.04 Cr against a loss of ₹0.53 CrBreak-even at a much lower base
28–30 Jul 2025EGM notice published: 28.29 lakh shares at ₹45—
14 Aug 2025Share price ₹53.65 (Trendlyne)Rally on capital raise
18 Aug 2025Ashokkumar N. Shah appointed independent director; committees reshuffledGovernance strengthening
20 Aug 2025EGM held; preferential issue approved—
4 Sep 2025Corporate action announcement (AGM-related)Routine
15–30 Sep 202533rd AGM notice and AGM (30 Sep 2025)—
13 Nov 2025Q2 FY26: revenue ₹10.74 Cr (−22.6% YoY); PAT ₹0.01 Cr against a loss of ₹0.81 Cr. Ongoing GST investigation disclosed (₹1 Cr deposited).Profitability marginal
18 Nov 2025—
3 Dec 2025Promoter-group director Aarasp Bodhanwala sells 60,986 shares (~₹33.9 lakh)Insider selling ahead of allotment
13 Dec 2025Preferential allotment completed: ₹11.18 Cr from 50 investorsEquity base +29%
15 Dec 2025Share price ₹50.45; P/E 26.1×; P/B 2.61× (ICICIdirect)—
19 Jan 2026GST SCN issued: ₹31.57 Cr ITC plus interest and penalty for FY22–FY25Exposure is about 2× FY26 revenue run-rate per quarter and about 1.25× post-issue net worth (derived)
3–4 Feb 2026SCN received (3 Feb) and disclosed to BSE under Reg. 30 (4 Feb)Key risk event
13 Feb 2026Q3 FY26: revenue ₹8.86 Cr (lowest in recent periods); net loss ₹0.62 Cr. Reg. 32 deviation statement filed.Deterioration
25 Feb 2026Share price ₹45.49; market cap ₹50.0 Cr (IIFL)—
14 Apr 2026Q4 FY26 Depositories Reg. 74(5) compliance certificateRoutine
30 May → 2 Jun 2026FY26 results board meeting rescheduled. FY26 results: revenue ₹44.4 Cr (−43%), net loss ₹1.13 Cr. Auditor flags going-concern material uncertainty, the GST SCN, SEBI/IT investigations and ₹18 Cr cheque litigation.Most material filing of the period
2 Jun 2026Chirag Bhatt & Associates appointed internal auditor for FY27—
12 Jun 2026Yogesh Keshariya appointed additional independent director—
19 & 24 Jun 2026Disclosures of reasons for delayed submission of FY26 resultsCompliance lapse
7 Aug 2026Board meeting intimation for Q1 FY27—
14 Aug 2026Q1 FY27: revenue ~₹16 Cr (highest since Q2 FY25). Result conflicts across sources: net loss ₹10.07 lakh (ScanX) versus profit ₹0.18 Cr (Bajaj Broking). Reg. 32 statement confirms full use of proceeds.Tentative volume recovery
20–21 Aug 2026Notice of 34th AGM published; revised annual report filed (per Investywise headline)—
26 Aug 2026Share price ₹49.01; market cap ₹54 Cr; P/B 2.1 (Value Research)—
5–11 Sep 2026Book closure (5–11 Sep). 34th AGM held 11 Sep 2026.—
11 Sep 2026SEBI SCN (Ref. SEBI/EAD3/MS/SM/DIS/23926/2026) begins adjudication against the company, its non-independent directors and others over the alleged wrongful ITC. Company says no impact on routine operations.Escalation: regulatory exposure now extends to directors

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

4 charts
Revenue by Segment (FY2022–FY2026): Polymer compounds segment revenue fell from INR 729.2 Mn in FY2022 to INR 444 Mn in FY2026.
Axel Polymers Limited — Revenue by Segment (FY2022–FY2026)
Series (INR Mn)FY2022FY2023FY2024FY2025FY2026
Polymer compounds segment revenue729.2826.51,279.2780.9444
Segment pre-tax income13.41722.93.1-12.5

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.